Turning Point Therapeutic... (TPTX)
NASDAQ: TPTX
· Real-Time Price · USD
75.49
0.09 (0.12%)
At close: Aug 15, 2022, 10:00 PM
Turning Point Therapeutics Revenue
Turning Point Therapeutics reported an annual revenue of $30.83M, reflecting a 23.32% growth. For the quarter ending June 30, 2022, Turning Point Therapeutics generated $119K in revenue.
Revenue (ttm)
30.83M
Revenue Growth
23.32%
Price / Sales Ratio
63.2
Revenue / Employee
115.46K
Employees
267
Market Cap
0
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2021 | 30.83M | +23.32% |
| Dec 31, 2020 | 25M | +Infinity% |
| Dec 31, 2019 | 0 | n/a |
| Dec 31, 2018 | 0 | n/a |
| Dec 31, 2017 | 0 | n/a |